Latest news
Krystal Biotech Reports Strong 2Q 2026 VYJUVEK Revenue Growth and Advances Multi-Program Genetic Medicines Pipeline - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTKrystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:06:00 GMTKrystal Biotech slides as investors appear to reset ahead of earnings - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 07:00:00 GMT